Riehen, Switzerland

Jean Ackermann

USPTO Granted Patents = 56 

 

Average Co-Inventor Count = 6.6

ph-index = 11

Forward Citations = 343(Granted Patents)

Forward Citations (Not Self Cited) = 322(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Basel, CH (1993 - 1998)
  • Riehen, CH (2000 - 2013)

Company Filing History:


Years Active: 1993-2013

Loading Chart...
Loading Chart...
56 patents (USPTO):Explore Patents

Title: Jean Ackermann: Innovator in Pharmaceutical Chemistry

Introduction: Jean Ackermann is a prominent inventor based in Riehen, Switzerland, recognized for his significant contributions to pharmaceutical chemistry. With a remarkable portfolio of 56 patents, Ackermann's work focuses on developing novel compounds aimed at treating various metabolic diseases. His innovative efforts have positioned him as a leading figure in the industry.

Latest Patents: Among his latest patents, Ackermann has developed azacyclic compounds that provide groundbreaking approaches to combat conditions such as diabetes, metabolic syndrome, and obesity. These compounds, characterized by a specific general formula, have shown promise as inhibitors of hormone-sensitive lipase (HSL). Additionally, his tetrahydrocinnoline derivatives present new pharmaceutical compositions intended for the treatment of metabolic disorders, further underscoring his dedication to advancing medical science.

Career Highlights: Ackermann is currently associated with Hoffmann-La Roche Inc., where he applies his expertise in pharmaceutical research and development. His ability to bridge complex scientific concepts with practical applications has led to significant advancements in the field.

Collaborations: Throughout his career, Jean Ackermann has collaborated with esteemed colleagues, including Johannes Aebi and Hans-Peter Maerki. These partnerships have facilitated a dynamic exchange of ideas and technologies, further enhancing the impact of their collective research.

Conclusion: Jean Ackermann's innovative contributions to pharmaceutical chemistry exemplify the vital role of inventors in the progression of medical treatments. His ongoing dedication to developing solutions for metabolic diseases underscores the importance of research and collaboration in achieving healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…